Miguel Cordova-Delgado
Overview
Explore the profile of Miguel Cordova-Delgado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arab A, Kashani B, Cordova-Delgado M, Scott E, Alemi K, Trueman J, et al.
Comput Biol Med
. 2024 Nov;
183:109324.
PMID: 39488053
Background: Cisplatin-induced ototoxicity remains a significant concern in pediatric cancer treatment due to its permanent impact on quality of life. Previously, genetic association analyses have been performed to detect genetic...
2.
Owen G, Cordova-Delgado M, Bustos B, Cerpa L, Gonzalez P, Morales-Pison S, et al.
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675222
Background: Pharmacogenomic knowledge as a biomarker for cancer care has transformed clinical practice, however, as current guidelines are primarily derived from Eurocentric populations, this limits their application in Latin America,...
3.
Pinto M, Munoz-Medel M, Retamal I, Bravo M, Latapiat V, Cordova-Delgado M, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613445
Recently, the combination of chemotherapy plus nivolumab (chemo-immunotherapy) has become the standard of care for advanced-stage gastric cancer (GC) patients. However, despite its efficacy, up to 40% of patients do...
4.
Acevedo F, Walbaum B, Muniz S, Petric M, Martinez R, Guerra C, et al.
Sci Rep
. 2022 Dec;
12(1):21145.
PMID: 36477462
Pathological complete response (pCR) after neoadjuvant chemotherapy (NCT) is associated with good long-term prognosis in breast cancer (BC) patients. However, some patients still recur and eventually die from this disease....
5.
Cordova-Delgado M, Pinto M, Pizarro G, Koch E, Vargas C, Hernandez M, et al.
J Gastrointest Oncol
. 2022 Sep;
13(4):2057-2064.
PMID: 36092312
Background: Early-onset gastric cancers (EOGC) are poor prognosis hard-to treat malignancies that affect young individuals (<45 years old). Case Description: Herein we describe the case of a 26-year-old female EOGC...
6.
Canteros D, Walbaum B, Cordova-Delgado M, Torrealba A, Reyes C, Navarro M, et al.
Ecancermedicalscience
. 2022 Aug;
16:1396.
PMID: 35919242
Introduction: Recently, contrast-enhanced mammography (CEM) has emerged as a reliable alternative to breast magnetic resonance imaging (MRI) for the assessment of pathological response in breast cancer patients. Our study sought...
7.
Cordova-Delgado M, Pinto M, Regonesi C, Cereceda L, Reyes J, Itriago L, et al.
J Pers Med
. 2022 Feb;
12(2).
PMID: 35207683
Major advances in sequencing technologies and targeted therapies have accelerated the incorporation of oncology into the era of precision medicine and "biomarker-driven" treatments. However, the impact of this approach on...
8.
Cordova-Delgado M, Fuentes-Retamal S, Palominos C, Lopez-Torres C, Guzman-Rivera D, Ramirez-Rodriguez O, et al.
Antioxidants (Basel)
. 2021 Oct;
10(10).
PMID: 34679752
Since breast cancer (BC) cells are dependent on mitochondrial bioenergetics for promoting proliferation, survival, and metastasis, mitochondria highlight as an important target for anticancer drug discovery. FRI-1, methyl 1, 3-dimethyl-5,...
9.
Cordova-Delgado M, Bravo M, Cumsille E, Hill C, Munoz-Medel M, Pinto M, et al.
BMC Cancer
. 2021 Sep;
21(1):1030.
PMID: 34525956
Background: Fluoropyrimidine plus platinum chemotherapy remains the standard first line treatment for gastric cancer (GC). Guidelines exist for the clinical interpretation of four DPYD genotypes related to severe fluoropyrimidine toxicity...
10.
Walbaum B, Puschel K, Medina L, Merino T, Camus M, Razmilic D, et al.
Breast Cancer Res Treat
. 2021 Jul;
189(2):561-569.
PMID: 34244869
Purpose: The implementation of national breast cancer (BC) screening programs in Latin America has been rather inconsistent. Instead, most countries have opted for "opportunistic" mammogram screenings on the population at...